These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 25271314)

  • 41. Autoimmune Hemolytic Anemia as a Complication of Congenital Anemias. A Case Series and Review of the Literature.
    Motta I; Giannotta J; Ferraresi M; Barbullushi K; Revelli N; Graziadei G; Barcellini W; Fattizzo B
    J Clin Med; 2021 Aug; 10(15):. PubMed ID: 34362222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rare case of refractory mixed autoimmune hemolytic anemia in a 6-year-old child: a case report.
    Hanna M; Carcao M
    J Med Case Rep; 2023 Oct; 17(1):418. PubMed ID: 37794483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Characteristics of warm autoimmune hemolytic anemia and Evans syndrome in adults].
    Michel M
    Presse Med; 2008 Sep; 37(9):1309-18. PubMed ID: 18644324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune hemolytic anemia--selected topics.
    Hoffman PC
    Hematology Am Soc Hematol Educ Program; 2006; ():13-8. PubMed ID: 17124033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How I manage Evans Syndrome and AIHA cases in children.
    Miano M
    Br J Haematol; 2016 Feb; 172(4):524-34. PubMed ID: 26625877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of idiopathic autoimmune hemolytic anemia in children. Review and report of two fatal cases in infancy.
    Johnson CA; Abildgaard CF
    Acta Paediatr Scand; 1976 May; 65(3):375-9. PubMed ID: 1274570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA.
    Laribi K; Bolle D; Ghnaya H; Sandu A; Besançon A; Denizon N; Truong C; Pineau-Vincent F; de Materre AB
    Ann Hematol; 2016 Apr; 95(5):765-9. PubMed ID: 26858026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature.
    Fattizzo B; Pasquale R; Bellani V; Barcellini W; Kulasekararaj AG
    Front Immunol; 2021; 12():791429. PubMed ID: 34899761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics and outcomes of autoimmune hemolytic anemia after pediatric allogeneic stem cell transplant.
    Hillier K; Harris EM; Berbert L; Pai SY; Grace RF
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29410. PubMed ID: 34709706
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cold AIHA and the best treatment strategies.
    Despotovic JM; Kim TO
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):90-95. PubMed ID: 36485161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-CD20 Treatment of Autoimmune Hemolytic Anemia Refractory to Corticosteroids and Azathioprine: A Pediatric Case Report and Mini Review.
    Makis A; Kanta Z; Kalogeropoulos D; Chaliasos N
    Case Rep Hematol; 2018; 2018():8471073. PubMed ID: 30225153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Refractory autoimmune hemolytic anemia in a systemic lupus erythematosus patient: A clinical case report.
    Crawford LR; Neparidze N
    Clin Case Rep; 2022 Mar; 10(3):e05583. PubMed ID: 35340637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].
    Ono K; Sato T; Iyama S; Tatekoshi A; Hashimoto A; Kamihara Y; Horiguchi H; Kikuchi S; Takada K; Hayashi T; Miyanishi K; Sato Y; Takimoto R; Kobune M; Kato J
    Rinsho Ketsueki; 2013 Nov; 54(11):2053-5. PubMed ID: 24305538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Small Paroxysmal Nocturnal Hemoglobinuria Clones in Autoimmune Hemolytic Anemia: Clinical Implications and Different Cytokine Patterns in Positive and Negative Patients.
    Fattizzo B; Giannotta J; Zaninoni A; Kulasekararaj A; Cro L; Barcellini W
    Front Immunol; 2020; 11():1006. PubMed ID: 32582157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The clinical features of the autoimmune hemolytic anemia with both warm and cold autoantibodies].
    Xing LM; Shao ZH; Liu H; Shi J; Bai J; Wang HQ; Tu MF; Sun J
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):42-4. PubMed ID: 16732941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monoclonal antibodies: new therapeutic agents for autoimmune hemolytic anemia?
    D'Arena G; Taylor RP; Cascavilla N; Lindorfer MA
    Endocr Metab Immune Disord Drug Targets; 2008 Mar; 8(1):62-8. PubMed ID: 18393924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Progress in diagnosis and treatment of autoimmune hemolytic anemia].
    Kamesaki T
    Rinsho Ketsueki; 2019; 60(9):1100-1107. PubMed ID: 31597833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Updates in the Management of Warm Autoimmune Hemolytic Anemia.
    Yui JC; Brodsky RA
    Hematol Oncol Clin North Am; 2022 Apr; 36(2):325-339. PubMed ID: 35282949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoimmune hemolytic anemia and thrombocytopenia attributed to an intrauterine contraceptive device.
    Khawandanah MO; Weiss SM; Cherry MA; Maymani H; Selby GB; Aster RH; George JN; Holter Chakrabarty JL
    Transfusion; 2015 Mar; 55(3):657-60. PubMed ID: 25208591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Autoimmune hemolytic anemia].
    Marmont A; Zanella A
    Recenti Prog Med; 2000 Oct; 91(10):517-24. PubMed ID: 11072741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.